The potential of tetrandrine as a protective agent for ischemic stroke

Molecules

Volumn 16, Issue 9, 2011, Pages 8020-8032

  Chen, Yun ^a,b   Tsai, Ya Hui ^a,b   Tseng, Sheng Hong ^c  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b YUAN ZE UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Alkaloid; Ischemic stroke; Tetrandrine

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; BENZYLISOQUINOLINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; TETRANDRINE;

ANIMAL; BRAIN INFARCTION; BRAIN ISCHEMIA; CHEMISTRY; HUMAN; PATHOPHYSIOLOGY; REPERFUSION INJURY; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BENZYLISOQUINOLINES; BRAIN INFARCTION; BRAIN ISCHEMIA; CALCIUM CHANNEL BLOCKERS; HUMANS; PLATELET AGGREGATION INHIBITORS; REPERFUSION INJURY;

EID: 80053273291     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16098020     Document Type: Review

References (80)

1. Woodruff, T.M.; Thundyil, J.; Tang, S.C.; Sobey, C.G.; Taylor, S.M.; Arumugam, T.V. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol. Neurodegener. 2011, 6, 11.
2. Arumugam, T.V.; Granger, D.N.; Mattson, M.P. Stroke and T-cells. Neuromol. Med. 2005, 7, 229-242. (Pubitemid 41507146)
3. Legos, J.J.; Barone, F.C. Update on pharmacological strategies for stroke: Prevention, acute intervention and regeneration. Curr. Opin. Investig. Drugs 2003, 4, 847-858. (Pubitemid 37265049)
4. Broughton, B.R.S.; Reutens, D.C.; Sobey, C.G. Apoptotic mechanisms after cerebral ischemia. Stroke 2009, 40, E331-E339.
5. Zheng, Z.; Yenari, M.A. Post-ischemic inflammation: Molecular mechanisms and therapeutic implications. Neurol. Res. 2004, 26, 884-892. (Pubitemid 39628566)
6. Ho, L.J.; Chang, D.M.; Chang, M.L.; Kuo, S.Y.; Lai, J.H. Mechanism of immunosuppression of the antirheumatic herb TWHf in human T cells. J. Rheumatol. 1999, 26, 14-22.
7. Chen, Y.; Chen, J.C.; Tseng, S.H. Effects of tetrandrine plus radiation on neuroblastoma cells. Anticancer Res. 2009, 29, 3163-3171.
8. Chen, Y.; Chen, J.C.; Tseng, S.H. Tetrandrine suppresses tumor growth and angiogenesis of gliomas in rats. Int. J. Cancer 2009, 124, 2260-2269.
9. Chen, Y.; Tseng, S.H. The potential of tetrandrine against gliomas. Anticancer Agents Med. Chem. 2010, 10, 534-542.
10. Lieberman, I.; Lentz, D.P.; Trucco, G.A.; Seow, W.K.; Thong, Y.H. Prevention by tetrandrine of spontaneous development of diabetes mellitus in BB rats. Diabetes 1992, 41, 616-619.
11. Wang, H.L.; Kilfeather, S.A.; Martin, G.R.; Page, C.P. Effects of tetrandrine on growth factor-induced DNA synthesis and proliferative response of rat pulmonary artery smooth muscle cells. Pulm. Pharmacol. Ther. 2000, 13, 53-60.
12. Zhang, Y.H.; Fang, L.H. Antagonism of morphine-induced antinociception by tetrandrine is dependent on serotonergic mechanism. Life Sci. 2001, 69, 1429-1439.
13. Li, S.Y.; Teh, B.S.; Seow, W.K.; Ling, L.H.; Thong, Y.H. Effect of tetrandrine on immunological response and cardiac transplant rejection in mice. Int. Arch. Allergy Appl. Immunol. 1989, 90, 169-173. (Pubitemid 19270533)
14. Chen, Y.; Lai, H.S.; Chiang, B.L.; Tseng, S.H.; Chen, W.J. Tetrandrine attenuated dendritic cell-mediated alloimmune responses and prolonged graft survival in mice. Planta Med. 2010, 76, 1424-1430.
15. Wu, J.M.; Chen, Y.; Chen, J.C.; Lin, T.Y.; Tseng, S.H. Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice. Cancer Lett. 2010, 287, 187-195.
16. Liu, Z.; Xu, Z.; Shen, W.; Li, Y.; Zhang, J.; Ye, X. Effect of pharmacologic preconditioning with tetrandrine on subsequent ischemia/reperfusion injury in rat liver. World J. Surg. 2004, 28, 620-624. (Pubitemid 38802802)
17. Shen, Y.C.; Chen, C.F.; Sung, Y.J. Tetrandrine ameliorates ischaemia-reperfusion injury of rat myocardium through inhibition of neutrophil priming and activation. Br. J. Pharmacol. 1999, 128, 1593-1601.
18. Wong, T.M.; Wu, S.; Yu, X.C.; Li, H.Y. Cardiovascular actions of Radix Stephaniae Tetrandrae: A comparison with its main component, tetrandrine. Acta Pharmacol. Sin. 2000, 21, 1083-1088. (Pubitemid 32012714)
19. Chen, Y.; Wu, J.M.; Lin, T.Z.; Wu, C.C.; Chiu, K.M.; Chang, B.F.; Tseng, S.H.; Chu, S.H. Tetrandrine ameliorated reperfusion injury of small bowel transplantation. J. Pediatr. Surg. 2009, 44, 2145-2152.
20. Li, Y.Y.; Li, X.L.; Yang, C.X.; Zhong, H.; Yao, H.; Zhu, L. Effects of tetrandrine and QYT on ICAM-1 and SOD gene expression in pancreas and liver of rats with acute pancreatitis. World J. Gastroenterol. 2003, 9, 155-159. (Pubitemid 36131300)
21. Mehta, S.L.; Manhas, N.; Rahubir, R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res. Rev. 2007, 54, 34-66. (Pubitemid 46498164)
22. 3 cells contribution to its antiproliferative effects. Life Sci. 2002, 70, 1185-1203.
23. Jin, Q.; Kang, C.; Soh, Y.; Sohn, N.W.; Lee, J.; Cho, Y.H.; Baik, H.H.; Kang, I. Tetrandrine cytotoxicity and its dual effect on oxidative stress-induced apoptosis through modulating cellular redox states in Neuro 2a mouse neuroblastoma cells. Life Sci. 2002, 71, 2053-2066.
24. Wang, G.; Lemos, J.R.; Iadecola, C. Herbal alkaloid tetrandrine: From an ion channel blocker to inhibitor of tumor proliferation. Trends Pharmacol. Sci. 2004, 25, 120-123. (Pubitemid 38264500)
25. + channel-mediated tumor cell proliferation and apoptosis. Apoptosis 2007, 12, 1837-1846. (Pubitemid 47498238)
26. Wang, G.; Lemos, J.R. Tetrandrine blocks a slow, large-conductance, Ca(2+)-activated potassium channel besides inhibiting a non-inactivating Ca2+ current in isolated nerve terminals of the rat neurohypophysis. Pflugers Arch. 1992, 421, 558-565.
27. Ishikawa, M.; Zhang, J.H.; Nanda, A. Granger, D.N. Inflammatory responses to ischemia and reperfusion in the cerebral microcirculation. Front. Biosci. 2004, 9, 1339-1347. (Pubitemid 39060847)
28. Hudome, S.; Palmer, C.; Roberts, R.L.; Mauger, D.; Housman, C.; Towfighi, J. The role of neutrophils in the production of hypoxic-ischemic brain injury in the neonatal rat. Pediatr. Res. 1997, 41, 607-616. (Pubitemid 27183952)
29. Matsuo, Y.; Onodera, H.; Shiga, Y.; Nakamura, M.; Ninomiya, M.; Kihara, T.; Kogure, K. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke 1994, 25, 1469-1475. (Pubitemid 24198597)
30. Mergenthaler, P.; Dirnagl, U.; Meisel, A. Pathophysiology of stroke: Lessons from animal models. Metab. Brain Dis. 2004, 19, 151-167. (Pubitemid 39361178)
31. Yilmaz, G.; Arumugam, T.V.; Stokes, K.Y.; Granger, D.N. Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 2006, 113, 2105-2012.
32. del Zoppo, G.J.; Milner, R.; Mabuchi, T.; Hung, S.; Wang, X.Y.; Berg, G.I.; Koziol, J.A. Microglial activation and matrix protease generation during focal cerebral ischemia. Stroke 2007, 38, 646-651. (Pubitemid 46184234)
33. Tuttolomondo, A.; di Raimondo, D.; di Sciacca, R.; Pinto, A.; Licata, G. Inflammatory cytokines in acute ischemic stroke. Curr. Pharm. Des. 2008, 14, 3574-3589.
34. Wang, Q.; Tang, X.N.; Yenari, M.A. The inflammatory response in stroke. J. Neuroimmunol. 2007, 184, 53-68. (Pubitemid 46365991)
35. Gelderblom, M.; Leypoldt, F.; Steinbach, K.; Behrens, D.; Choe, C.U.; Siler, D.A.; Arumugam, T.V.; Orthey, E.; Gerloff, C.; Tolosa, E.; et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009, 40, 1849-1857.
36. Jin, R.; Yang, G.J.; Li, G.H. Inflammatory mechanisms in ischemic stroke: Role of inflammatory cells. J. Leukoc Biol. 2010, 87, 779-789.
37. Goussev, A.V.; Zhang, Z.G.; Anderson, D.C.; Chopp, M. P-selectin antibody reduces hemorrhage and infarct volume resulting from MCA occlusion in the rat. J. Neurol. Sci. 1998, 161, 16-22. (Pubitemid 28559178)
38. Zhang, R.L.; Chopp, M.; Jiang, N.; Tang, W.X.; Prostak, J.; Manning, A.M.; Anderson, D.C. Antiintercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 1995, 26, 1438-1443.
39. Furuya, K.; Takeda, H.; Azhar, S.; McCarron, R.M.; Chen, Y.; Ruetzler, C.A.; Wolcott, K.M.; DeGraba, T.J.; Rothlein, R.; Hugli, T.E.; et al. Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody-A bedside-to-bench study. Stroke 2001, 32, 2665-2674. (Pubitemid 33055322)
40. Schneider, D.; Berrouschot, J.; Brandt, T.; Hacke, W.; Ferbert, A.; Norris, S.H.; Polmar, S.H.; Schafer, E. Safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody): An open-label, dose escalation study in patients hospitalized for acute stroke. Eur. Neurol. 1998, 40, 78-83. (Pubitemid 28369610)
41. Chang, D.M.; Chang, W.Y.; Kuo, S.Y.; Chang, M.L. The effects of traditional antirheumatic herbal medicines on immune response cells. J. Rheumatol. 1997, 24, 436-441.
42. Lin, T.Y.; Tseng, S.H.; Li, S.J.; Chen, J.C.; Shieh, J.S.; Chen, Y. Tetrandrine increased the survival rate of mice with lipopolysaccharide-induced endotoxemia. J. Trauma 2009, 66, 411-417.
43. Wong, C.W.; Seow, W.K.; O'Callaghan, J.W.; Thong, Y.H. Comparative effects of tetrandrine and berbamine on subcutaneous air pouch inflammation induced by interleukin-1, tumor necrosis factor and platelet-activating factor. Agents Actions 1992, 36, 112-118.
44. Wong, C.W.; Thong, Y.H.; Seow, W.K. Comparative effects of tetrandrine and berbamine on guineapig airway microvascular leakage induced by platelet-activating factor and other allergic mediators. Int. J. Immunopharmacol. 1993, 15, 185-193. (Pubitemid 23096243)
45. Shen, Y.C.; Chen, C.F.; Wang, S.Y.; Sung, Y.J. Impediment to calcium influx and reactive oxygen production accounts for the inhibition of neutrophil Mac-1 up-regulation and adhesion by tetrandrine. Mol. Pharmacol. 1999, 55, 186-193.
46. Allen, C.L.; Bayraktutan, U. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int. J. Stroke 2009, 4, 461-470.
47. Choi, K.; Kim, J.; Kim, G.W.; Choi, C. Oxidative stress-induced necrotic cell death via mitochondira-dependent burst of reactive oxygen species. Curr. Neurovasc. Res. 2009, 6, 213-222.
48. Suh, S.W.; Shin, B.S.; Ma, H.L.; van Hoecke, M.; Brennan, A.M.; Yenari, M.A.; Swanson, R.A. Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. Ann. Neurol. 2008, 64, 654-663.
49. Girouard, H.; Iadecola, C. Neurovascular coupling in the normal brain and in hypertension, stroke, and alzheimer disease. J. Appl. Physiol. 2006, 100, 328-335. (Pubitemid 43671125)
50. Hall, E.D. Inhibition of lipid peroxidation in central nervous system trauma and ischemia. J. Neurol. Sci. 1995, 134, 79-83.
51. Im, J.Y.; Kim, D.; Paik, S.G.; Han, P.L. Cyclooxygenase-2-dependent neuronal death proceeds via superoxide anion generation. Free Radic. Biol. Med. 2006, 41, 960-972. (Pubitemid 44247547)
52. Lau, A.T.Y.; Wang, Y.; Chiu, J.F. Reactive oxygen species: Current knowledge and applications in cancer research and therapeutic. J. Cell. Biochem. 2008, 104, 657-667. (Pubitemid 351671652)
53. Klaunig, J.E.; Kamendulis, L.M. The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 2004, 44, 239-267. (Pubitemid 38263841)
54. Iwashita, A.; Maemoto, T.; Nakada, H.; Shima, I.; Matsuoka, N.; Hisajima, H. A novel potent radical scavenger, 8-(4-fluorophenyl)-2-((2E)-3-phenyl-2- propenoyl)-1,2,3,4-tetrahydropyrazolo [5,1-c][1,2,4]triazine (FR210575), prevents neuronal cell death in cultured primary neurons and attenuates brain injury after focal ischemia in rats. J. Pharmacol. Exp. Ther. 2003, 307, 961-968. (Pubitemid 37494213)
55. Sydserff, S.G.; Borelli, A.R.; Green, A.R.; Cross, A.J. Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window. Br. J. Pharmacol. 2002, 135, 103-112. (Pubitemid 34102103)
56. Lees, K.R.; Zivin, J.A.; Ashwood, T.; Davalos, A.; Davis, S.M.; Diener, H.; Grotta, J.; Lyden, P.; Shuaib, A.; Hardemark, H.; et al. NXY-059 for acute ischemic stroke. N. Engl. J. Med. 2006, 354, 588-600. (Pubitemid 43209106)
57. Shuaib, A.; Lees, K.R.; Lyden, P.; Grotta, J.; Davalos, A.; Davis, S.M.; Diener, H.; Ashwood, T.; Wasiewski, W.W.; Emeribe, U. NXY-059 for the treatment of acute ischemic stroke. N. Engl. J. Med. 2007, 357, 562-571. (Pubitemid 47236281)
58. Koh, S.B.; Ban, J.Y.; Lee, B.Y.; Seong, Y.H. Protective effects of fangchinoline and tetrandrine on hydrogen peroxide-induced oxidative neuronal cell damage in cultured rat cerebellar granule cells. Planta Med. 2003, 69, 506-512. (Pubitemid 36870623)
59. Fernandes, M.A.; Custodio, J.B.; Santos, M.S.; Moreno, A.J.M.; Vicente, J.A.F. Tetrandrine concentrations not affecting oxidative phosphorylation protect rat liver mitochondria from oxidative stress. Mitochondrion 2006, 6, 176-185. (Pubitemid 44309457)
60. Ye, J.; Ding, M.; Zhang, X.; Rojanasakul, Y.; Shi, X. On the role of hydroxyl radical and the effect of tetrandrine on nuclear factor-kappaB activation by phorbol 12-myristate 13-acetate. Ann. Clin. Lab. Sci. 2000, 30, 65-71. (Pubitemid 30078306)
61. Shi, X.; Mao, Y.; Saffiotti, U.; Wang, L.; Rojanasakul, Y.; Leonard, S.S.; Vallyathan, V. Antioxidant activity of tetrandrine and its inhibition of quartz-induced lipid peroxidation. J. Toxicol. Environ. Health 1995, 46, 233-248.
62. Cao, Z.F. Scavenging effect of tetrandrine on active oxygen radicals. Planta Med. 1996, 62, 413-414.
63. Castranova, V. Generation of oxygen radicals and mechanisms of injury prevention. Environ. Health Perspect. 1994, 102, 65-68.
64. Castranova, V.; Kang, J.H.; Moore, M.D.; Pailes, W.H.; Frazer, D.G.; Schwegler-Berry, D. Inhibition of stimulant-induced activation of phagocytic cells with tetrandrine. J. Leukoc. Biol. 1991, 50, 412-422.
65. Chen, F.; Sun, S.; Kuhn, D.C.; Lu, Y.; Gaydos, L.J.; Shi, X.; Demers, L.M. Tetrandrine inhibits signal-induced NF-kB activation in rat alveolar macrophages. Biochem. Biophys. Res. Commun. 1997, 231, 99-102. (Pubitemid 27212116)
66. Shen, Y.C.; Chou, C.J.; Chiou, W.F.; Chen, C.F. Anti-inflammatory effects of the partially purified extract of radix stephaniae tetrandrae: Comparative studies of its active principles tetrandrine and fangchinoline on human polymorphonuclear leukocyte functions. Mol. Pharmacol. 2001, 60, 1083-1090.
67. Sekiya, N.; Hikiami, H.; Yokoyama, K.; Kouta, K.; Sakakibara, I.; Shimada, Y.; Terasawa, K. Inhibitory effects of Stephania tetrandra S. Moore on free radical-induced lysis of rat blood cells. Biol. Pharm. Bull. 2005, 28, 667-670. (Pubitemid 40879935)
68. Zhou, Y.D.; Fang, X.F.; Cui, Z.J. UVA-induced calcium oscillation in rat mast cells. Cell Calcium 2009, 45, 18-28.
69. Steg, P.G.; Dorman, S.H.; Amarenco, P. Atherothromobosis and the role of antiplatelet therapy. J. Thromb. Haemost. 2011, 9, 325-332.
70. Nieswandt, B.; Pleines, I.; Bender, M. Platelet adhesion and activation mechanisms in arterial thrombosis and ischemic stroke. J. Thromb. Haemost. 2011, 9, 92-104.
71. Hashizume, T.; Yamaguchi, H.; Sato, T.; Fujii, T. Suppressive effect of biscoclaurine alkaloids on agonist-induced activation of phospholipase A2 in rabbit platelets. Biochem. Pharmacol. 1991, 41, 419-423.
72. Kim, H.S.; Zhang, Y.H.; Fang, L.H.; Yun, Y.P.; Lee, H.K. Effects of tetrandrine and fangchinoline on human platelet aggregation and thromboxane B2 formation. J. Ethnopharmacol. 1999, 66, 241-246.
73. Teh, B.S.; Ioannoni, B.; Seow, W.K.; McCormack, J.G.; Thong, Y.H. Suppression by tetrandrine of human platelet aggregation induced by platelet-activating factor and other stimulants. Int. Arch. Allergy Appl. Immunol. 1989, 88, 267-272. (Pubitemid 19132201)
74. Kim, H.S.; Zhang, Y.H.; Yun, Y.P. Effects of tetrandrine and fangchinoline on experimental thrombosis in mice and human platelet aggregation. Planta Med. 1999, 65, 135-138.
75. Chang, K.H.; Chen, M.L.; Chen, H.C.; Huang, Y.W.; Wu, T.Y.; Chen, Y.J. Enhancement of radiosensitivity in human glioblastoma U138MG cells by tetrandrine. Neoplasma 1999, 46, 196-200. (Pubitemid 29398321)
76. Sun, F.; Liu, T.P. Tetrandrine vs nicardipine in cerebral ischemia-reperfusion damages in Gerbils. Acta Pharmacol. Sin. 1995, 16, 145-148.
77. Gralla, E.J.; Coleman, G.L.; Jonas, A.M. Toxicology studies with d-tetrandrine (NSC-77037), a plant alkaloid with vascular and lymphotoxic effects in dogs and monkeys. Cancer Chemother. Rep. Part 3 1974, 5, 79-85.
78. Herman, E.H.; Chadwick, D.P. Cardiovascular effects of d-Tetrandrine. Pharmacology 1974, 12, 97-109.
79. Hui, S.C.G.; Chan, T.Y.; Chen, Y.Y. Tetrandrine inhibits lipid peroxidation but lacks reactivity towards superoxide anion and hydrogen peroxide. Pharmacol. Toxicol. 1996, 78, 200-201.
80. Liu, S.J.; Zhou, S.W.; Xue, C.S. Effect of tetrandrine on neutrophilic recruitment response to brain ischemia/reperfusion. Acta. Pharmacol. Sin. 2001, 22, 971-975